Q32 Bio (QTTB) Capital Expenditures Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 227.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.11% |
| Dec 31, 2025 | 374.42% |
| Jun 30, 2025 | -30.14% |
| Mar 31, 2025 | 61.17% |
| Dec 31, 2024 | -65.66% |
| Sep 30, 2024 | 85.66% |
| Jun 30, 2024 | 32.16% |
| Mar 31, 2024 | -47.98% |
| Sep 30, 2023 | -47.62% |
| Jun 30, 2023 | -55.83% |
| Mar 31, 2023 | -76.89% |
| Dec 31, 2022 | 26.82% |
| Sep 30, 2022 | 26.00% |
| Jun 30, 2022 | -52.23% |
| Mar 31, 2022 | -77.63% |
| Dec 31, 2021 | -76.49% |
| Sep 30, 2021 | -26.25% |
| Jun 30, 2021 | -29.54% |
| Mar 31, 2021 | 211.62% |
| Dec 31, 2020 | -114.89% |
| Sep 30, 2020 | -52.60% |
| Jun 30, 2020 | 72.78% |
| Mar 31, 2020 | -21.85% |